|
Çѱ¹MSD À¯ÇÑȸ»ç |
CRA ´Ù¼ö ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
2³â¡è |
ä¿ë½Ã |
08.05 |
|
|
ÁöÀÌÇコÄɾîÄÚ¸®¾Æ(ÁÖ) |
ÁöÀÌÇコÄɾîÄÚ¸®¾Æ(ÁÖ) Service Solutions Analyst »ç¿ø´ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
2³â¡è |
ä¿ë½Ã |
03.06 |
|
|
(ÁÖ)¿¤¿¡½ºÄÉÀ̱۷ιúÆĸ¶¼ºñ½º |
ERºÎ¼ ÆÀÀå / ERA °æ·Â/ PL/ A.PL ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
1³â¡è |
ä¿ë½Ã |
10.05 |
|
|
(ÁÖ)¸ÞµðÇïÇÁ¶óÀÎ |
CRºÎ¼ SSU ¾÷¹« Á¤±ÔÁ÷¿ø ä¿ë°ø°í
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
SSU |
1³â¡è |
»ó½Ãä¿ë |
02.23 |
|
|
(ÁÖ)¿¤¿¡½ºÄÉÀ̱۷ιúÆĸ¶¼ºñ½º |
2023 »ó¹Ý±â º¸ÈÆƯº°Ã¤¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
1³â¡è |
ä¿ë½Ã |
02.17 |
|
|
(ÁÖ)¿¤¿¡½ºÄÉÀ̱۷ιúÆĸ¶¼ºñ½º |
CMºÎ¼ CM Manager °æ·Â ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
1³â¡è |
ä¿ë½Ã |
11.27 |
|
|
(ÁÖ)¿¤¿¡½ºÄÉÀ̱۷ιúÆĸ¶¼ºñ½º |
[LSK global PS] SP / ERA / PL ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
1³â¡è |
ä¿ë½Ã |
12.02 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
MSD Clinical research associate(CRA)´Ù¼ö ¸ðÁý Áß
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
11.06 |
|
|
ÁöÀÌÇコÄɾîÄÚ¸®¾Æ |
[GE Healthcare] Lead Finance Analyst - FP&A »ç¿ø´ë¸®±Þ
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
1³â¡è |
ä¿ë½Ã |
01.31 |
|
|
ÁöÀÌÇコÄɾîÄÚ¸®¾Æ |
[GE Healthcare] [°£È£»ç/ÀÓ»óº´¸®»ç ¿ì´ë]ÀÓ»óÁö¿ø(App) ´ã
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
1³â¡è |
ä¿ë½Ã |
02.04 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
RA Specialist ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
1³â¡è |
ä¿ë½Ã |
06.20 |
|
|
(ÁÖ)¿¤¿¡½ºÄÉÀ̱۷ιúÆĸ¶¼ºñ½º |
BDºÎ¼ BD Manager ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
1³â¡è |
ä¿ë½Ã |
08.03 |
|
|
ÁöÀÌÇコÄɾîÄÚ¸®¾Æ |
Commercial Operation Specialist(»ç¿ø~´ë¸®±Þ)
¼¿ï Áß±¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
1³â¡è |
ä¿ë½Ã |
01.09 |
|
|
Çѱ¹Organon |
Çѱ¹Organon Market Access ´ã´çÀÚ ¸ðÁý
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
1³â¡è |
ä¿ë½Ã |
01.15 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
CTC Á¤±ÔÁ÷ 1¸í ¸ðÁý
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CTA/CRC |
½ÅÀÔ |
ä¿ë½Ã |
10.24 |
|